Shanghai Desano Bio-Pharmaceutical Co., Ltd.
FDA inspection history in Shanghai, China, 2019
- 1
- Form 483
Every document, by year
- Form 483
2019: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2019One Form 483, at Shanghai, China.
Cited most
Across all Shanghai Desano Bio-Pharmaceutical Co. observations on file
- 21 CFR 211.110Sampling and testing of in-process materials and drug products1
- 21 CFR 211.22Responsibilities of quality control unit1
- 21 CFR 211.67Equipment cleaning and maintenance1
- 21 CFR 211.68Automatic, mechanical, and electronic equipment1
The complete Shanghai Desano Bio-Pharmaceutical Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Shanghai, China
One Form 483 · 2019 · 4 observations
Latest: Form 483, Aug 2, 2019 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2019-08-02 | 483 Form 483 | Shanghai, China | 4 | $99 |
Investigators on these documents
FEI number 3008345655 · most recent document Aug 2, 2019
About Shanghai Desano Bio-Pharmaceutical Co., Ltd.
How many FDA Form 483s has Shanghai Desano Bio-Pharmaceutical Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Shanghai Desano Bio-Pharmaceutical Co., Ltd.; the most recent is dated Aug 2, 2019.
When was Shanghai Desano Bio-Pharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Shanghai Desano Bio-Pharmaceutical Co., Ltd. is a Form 483 dated Aug 2, 2019, for the site in Shanghai, China.
What did FDA cite at Shanghai Desano Bio-Pharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Shanghai Desano Bio-Pharmaceutical Co., Ltd. are 21 CFR 211.110 (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.22 (Responsibilities of quality control unit), 1 time; 21 CFR 211.67 (Equipment cleaning and maintenance), 1 time.